Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001015820-14-000016
Filing Date
2014-05-07
Accepted
2014-05-07 16:30:19
Documents
2
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 6-K a2014q1pr6-k.htm 6-K 331329
2 qlogoandlineregist.jpg GRAPHIC 88990
  Complete submission text file 0001015820-14-000016.txt   455042
Mailing Address SPOORSTRAAT 50 KJ VENLO P7 5911
Business Address SPOORSTRAAT 50 KJ VENLO P7 5911 31-77-320-8400
QIAGEN NV (Filer) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-28564 | Film No.: 14821403
SIC: 2836 Biological Products, (No Diagnostic Substances)